You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Akeso
since
auto-detected in 1 stories
9 days ago
An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.
page 1 of 1